Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition.

Abstract:

:The epithelial-mesenchymal transition (EMT) has been recognized to occur during embryonic development, fibrosis, and tumor metastasis. Nuclear factor (NF)-κB plays a central role in mediating the inflammation and wound-healing responses during liver fibrogenesis. However, the involvement of NF-κB during EMT in liver cells remains unidentified. To develop a therapeutic approach to EMT during liver fibrosis, we examined the inhibition of transcription factor NF-κB, using a decoy oligodeoxynucleotide (ODN) strategy in liver fibrosis in vitro and in vivo. NF-κB decoy ODN contains consensus binding sequences of the NF-κB-binding site. NF-κB decoy ODN effectively suppresses transforming growth factor-β(1)-induced EMT in AML12 murine hepatocytes. Liver fibrosis induced by CCl(4) administration was suppressed by NF-κB decoy ODN. Furthermore, NF-κB decoy ODN was shown to inhibit the EMT process in fibrotic liver in vivo. This study demonstrates the feasibility of NF-κB decoy ODN treatment for preventing liver fibrosis via EMT processes.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Kim KH,Lee WR,Kang YN,Chang YC,Park KK

doi

10.1089/hum.2013.106

subject

Has Abstract

pub_date

2014-08-01 00:00:00

pages

721-9

issue

8

eissn

1043-0342

issn

1557-7422

journal_volume

25

pub_type

杂志文章
  • Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.

    abstract::Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene that result in the absence of functional protein. In the majority of cases these are out-of-frame deletions that disrupt the reading frame. Several attempts have been made to restore the dystrophin mRNA reading frame by modulation of pre-m...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.061

    authors: Arechavala-Gomeza V,Graham IR,Popplewell LJ,Adams AM,Aartsma-Rus A,Kinali M,Morgan JE,van Deutekom JC,Wilton SD,Dickson G,Muntoni F

    更新日期:2007-09-01 00:00:00

  • lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.

    abstract::Gene transfer of reporter genes may trigger immune responses against the heterologous protein resulting in shortening of gene expression and inflammation. We generated transgenic rats expressing the lacZ gene under the control of the human immunodeficiency virus type 1 (HIV-1) long-terminal repeat (LTR) (HIV-lacZ) to ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402760128603

    authors: Ménoret S,Aubert D,Tesson L,Braudeau C,Pichard V,Ferry N,Anegon I

    更新日期:2002-07-20 00:00:00

  • A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line.

    abstract::Dystrophic epidermolysis bullosa (DEB) comprises a family of inherited blistering skin disorders for which no corrective therapy currently exists. In the most severe form, the Hallopeau-Siemens subtype (RDEB-HS), the epidermal adhesion protein collagen VII is absent from the skin as a consequence of null mutations in ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260201743

    authors: Mecklenbeck S,Compton SH,Mejía JE,Cervini R,Hovnanian A,Bruckner-Tuderman L,Barrandon Y

    更新日期:2002-09-01 00:00:00

  • Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.

    abstract::The use of viral thymidine kinase (TK) gene coupled with the administration of ganciclovir to render cancer cell death has been studied extensively. Many of these experiments utilized retrovirus to transfer the TK gene under the control of a nonspecific promoter. Because nonspecific expression of the viral TK gene may...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.4-463

    authors: Su H,Chang JC,Xu SM,Kan YW

    更新日期:1996-03-01 00:00:00

  • Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty.

    abstract::Blood vessels are among the easiest targets for gene therapy. However, no data are available about the safety and feasibility of intracoronary gene transfer in humans. We studied the safety and efficacy of catheter-mediated vascular endothelial growth factor (VEGF) plasmid/liposome (P/L) gene transfer in human coronar...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1089/10430340050016003

    authors: Laitinen M,Hartikainen J,Hiltunen MO,Eränen J,Kiviniemi M,Närvänen O,Mäkinen K,Manninen H,Syvänne M,Martin JF,Laakso M,Ylä-Herttuala S

    更新日期:2000-01-20 00:00:00

  • Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver.

    abstract::This multicenter phase I/II study evaluated the safety, pharmacokinetics, and antitumor effects of repeated doses of NV1020, a genetically engineered oncolytic herpes simplex virus, in patients with advanced metastatic colorectal cancer (mCRC). Patients with liver-dominant mCRC received four fixed NV1020 doses via wee...

    journal_title:Human gene therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1089/hum.2010.020

    authors: Geevarghese SK,Geller DA,de Haan HA,Hörer M,Knoll AE,Mescheder A,Nemunaitis J,Reid TR,Sze DY,Tanabe KK,Tawfik H

    更新日期:2010-09-01 00:00:00

  • Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trial.

    abstract::Immunotherapy with whole cell cancer vaccines has been tested in various tumor types. This study investigated the safety profile and antitumor activity of an allogeneic prostate carcinoma cell line, LNCaP, expressing recombinant human interleukin-2 and human interferon-gamma. Thirty HLA-A*0201-matched patients with pr...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.101

    authors: Brill TH,Kübler HR,Pohla H,Buchner A,Fend F,Schuster T,van Randenborgh H,Paul R,Kummer T,Plank C,Eisele B,Breul J,Hartung R,Schendel DJ,Gansbacher B

    更新日期:2009-12-01 00:00:00

  • Inactivation of Adeno-Associated Viral Vectors by Oxidant-Based Disinfectants.

    abstract::Adeno-associated viral (AAV) vectors are becoming increasingly popular in basic research as well as in clinical gene therapy. Due to its exceptional resistance against physical and chemical stress, however, the increasing use of AAV in laboratories and clinics around the globe raises safety concerns. Proper decontamin...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.120

    authors: Korte J,Mienert J,Hennigs JK,Körbelin J

    更新日期:2020-11-06 00:00:00

  • Lentiviral-mediated RNA interference.

    abstract::RNA interference (RNAi) is a form of posttranscriptional gene silencing mediated by short double-stranded RNA, known as small interfering RNA (siRNA). These siRNAs are capable of binding to a specific mRNA sequence and causing its degradation. The recent demonstration of a plasmid vector that directs siRNA synthesis i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402320987888

    authors: Abbas-Terki T,Blanco-Bose W,Déglon N,Pralong W,Aebischer P

    更新日期:2002-12-10 00:00:00

  • Fusion of the human immunodeficiency virus type 1 tat protein transduction domain to thymidine kinase increases bystander effect and induces enhanced tumor killing in vivo.

    abstract::The clinical success of suicide gene therapy using herpes simplex virus type 1 thymidine kinase (TK) is largely dependent on the capacity of this enzyme to effectively induce the death of bystander cells. We have shown that fusion of TK to an 11-amino acid peptide from the basic domain of the human immunodeficiency vi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.1389

    authors: Tasciotti E,Giacca M

    更新日期:2005-12-01 00:00:00

  • Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus.

    abstract::Interleukin-12 (IL-12) is a cytokine that exhibits pleiotropic effects on lymphocytes and natural killer cells and has been shown to have promise for the immunotherapy of cancer. The combination of the immune costimulatory molecule B7.1 and IL-12 has been shown to be synergistic for T cell activation. By transfecting ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.9-1125

    authors: Anderson R,Macdonald I,Corbett T,Hacking G,Lowdell MW,Prentice HG

    更新日期:1997-06-10 00:00:00

  • Endothelial Progenitor Cells as Shuttle of Anticancer Agents.

    abstract::Cell therapies are treatments in which stem or progenitor cells are stimulated to differentiate into specialized cells able to home to and repair damaged tissues. After their discovery, endothelial progenitor cells (EPCs) stimulated worldwide interest as possible vehicles to perform autologous cell therapy of tumors. ...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2016.066

    authors: Laurenzana A,Margheri F,Chillà A,Biagioni A,Margheri G,Calorini L,Fibbi G,Del Rosso M

    更新日期:2016-10-01 00:00:00

  • ssDNA and the Argonautes: The Quest for the Next Golden Editor.

    abstract::Genome engineering has gone mainstream because of breakthroughs in defining and harnessing naturally occurring, customizable DNA recognition cursors (protein or RNA-guided). At present, most gene editing relies on these cursors to direct custom DNA endonucleases to a specific genomic sequence to induce a double-strand...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2016.071

    authors: Martínez-Gálvez G,Ata H,Campbell JM,Ekker SC

    更新日期:2016-06-01 00:00:00

  • Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.

    abstract::Deficiency of glycogen branching enzyme (GBE) causes glycogen storage disease type IV (GSD IV), which is characterized by the accumulation of a less branched, poorly soluble form of glycogen called polyglucosan (PG) in multiple tissues. This study evaluates the efficacy of gene therapy with an adeno-associated viral (...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2016.099

    authors: Yi H,Zhang Q,Brooks ED,Yang C,Thurberg BL,Kishnani PS,Sun B

    更新日期:2017-03-01 00:00:00

  • DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.

    abstract::La Crosse virus (LACV)-mediated encephalitis is the most frequently reported arboviral disease in the United States, but to date no vaccine against this virus is available. We have established a new animal model, genetically targeted mice lacking a functional interferon type I receptor (IFNAR-1). These mice show an ag...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950017653

    authors: Schuh T,Schultz J,Moelling K,Pavlovic J

    更新日期:1999-07-01 00:00:00

  • Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line.

    abstract::Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene therapy. Thanks to the extended knowledge of the molecular biology of the HIV life cycle, many different strategies have been developed including transdominant modifications of HIV proteins, RNA decoys, antisense RNA, ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.5-621

    authors: Michienzi A,Conti L,Varano B,Prislei S,Gessani S,Bozzoni I

    更新日期:1998-03-20 00:00:00

  • Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor.

    abstract::Activation of T cells is necessary for efficient retroviral-mediated gene transfer. In addition, if the population of infused cells is to be limited to transduced cells, a means of positive selection is required. We describe a clinical scale procedure for activation of donor T cells with anti-CD3/CD28 beads followed b...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340252939087

    authors: Orchard PJ,Blazar BR,Burger S,Levine B,Basso L,Nelson DM,Gordon K,McIvor RS,Wagner JE,Miller JS

    更新日期:2002-05-20 00:00:00

  • hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.

    abstract::Eleven patients with moderate to severe erectile dysfunction (ED) were given a single-dose corpus cavernosum injection of hMaxi-K, a "naked" DNA plasmid carrying the human cDNA encoding hSlo (for human slow-poke), the gene for the alpha, or pore-forming, subunit of the human smooth muscle Maxi-K channel. Three patient...

    journal_title:Human gene therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1089/hum.2006.17.1165

    authors: Melman A,Bar-Chama N,McCullough A,Davies K,Christ G

    更新日期:2006-12-01 00:00:00

  • Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery.

    abstract::The recombinant adenoviral (Ad) vector is being considered as a cancer vaccine platform because it efficiently induces immune responses to tumor antigens by intradermal immunization. The aims of this study were to evaluate the potential toxicities and biodistribution after a single dose or six weekly intradermal doses...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.705

    authors: Plog MS,Guyre CA,Roberts BL,Goldberg M,St George JA,Perricone MA

    更新日期:2006-07-01 00:00:00

  • Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates.

    abstract::An E1-, E2a-, E3-deleted adenoviral vector (Av3H82) encoding an epitope-tagged B domain-deleted human factor VIII cDNA (flagged FVIII) was evaluated in nonhuman primates. Twelve cynomolgus monkeys received intravenous administration of Av3H82; 6 monkeys received 6 x 10(11) particles/kg and another 6 received 3 x 10(12...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950016401

    authors: Brann T,Kayda D,Lyons RM,Shirley P,Roy S,Kaleko M,Smith T

    更新日期:1999-12-10 00:00:00

  • Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy.

    abstract::Mutations in the gene encoding the peroxisomal ATP-binding cassette transporter (ABCD1) cause elevations in very long-chain fatty acids (VLCFAs) and the neurodegenerative disease adrenoleukodystrophy (ALD). In most adults, this manifests as the spinal cord axonopathy adrenomyeloneuropathy (AMN). A challenge in virus-b...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2018.079

    authors: Gong Y,Berenson A,Laheji F,Gao G,Wang D,Ng C,Volak A,Kok R,Kreouzis V,Dijkstra IM,Kemp S,Maguire CA,Eichler F

    更新日期:2019-05-01 00:00:00

  • MALAT1-Driven Inhibition of Wnt Signal Impedes Proliferation and Inflammation in Fibroblast-Like Synoviocytes Through CTNNB1 Promoter Methylation in Rheumatoid Arthritis.

    abstract::Fibroblast-like synoviocytes (FLSs) participate in the pathogenesis of rheumatoid arthritis (RA). Emerging evidence has highlighted the role of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) and its potential involvement in RA. In this study, we test the hypothesis that the MALAT1 ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2018.212

    authors: Li GQ,Fang YX,Liu Y,Meng FR,Wu X,Zhang CW,Zhang Y,Liu D,Gao B

    更新日期:2019-08-01 00:00:00

  • Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.

    abstract::MDA-MB-231, an HLA-A2(+), HER2/neu(+) allogeneic breast cancer cell line genetically modified to express the costimulatory molecule CD80 (B7-1), was used to vaccinate 30 women with previously treated stage IV breast cancer. Expression of CD80 conferred the ability to deliver a costimulatory signal and thereby improved...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/104303403322124828

    authors: Dols A,Smith JW 2nd,Meijer SL,Fox BA,Hu HM,Walker E,Rosenheim S,Moudgil T,Doran T,Wood W,Seligman M,Alvord WG,Schoof D,Urba WJ

    更新日期:2003-07-20 00:00:00

  • Stem-Cell Therapy Advances in China.

    abstract::Stem-cell therapy is a promising method for treating patients with a wide range of diseases and injuries. Increasing government funding of scientific research has promoted rapid developments in stem-cell research in China, as evidenced by the substantial increase in the number and quality of publications in the past 5...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2017.224

    authors: Hu L,Zhao B,Wang S

    更新日期:2018-02-01 00:00:00

  • Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B.

    abstract::Human hematopoietic stem cells (HSCs) are poorly transduced by vectors based on adenovirus serotype 5 (Ad5). This is primarily due to the paucity of the coxsackievirus-Ad receptor on these cells. In an attempt to change the tropism of Ad5, we constructed a series of chimeric E1-deleted Ad5 vectors in which the shaft a...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401753204562

    authors: Knaän-Shanzer S,Van Der Velde I,Havenga MJ,Lemckert AA,De Vries AA,Valerio D

    更新日期:2001-11-01 00:00:00

  • Antitumor therapy based on cellular competition.

    abstract::A major obstacle for the efficacy of cancer gene therapy is the need to transduce a high proportion of tumor cells with genes that directly or indirectly cause their death. During the formation of certain organs, cells compete among themselves to colonize the whole tissue. We reasoned that cell competition could be us...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2008.144

    authors: Martinez-Quintanilla J,Cascallo M,Fillat C,Alemany R

    更新日期:2009-07-01 00:00:00

  • Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.

    abstract::Isolated methylmalonic acidemia (MMA), a group of autosomal recessive inborn errors of metabolism, is most commonly caused by complete (mut(0)) or partial (mut(-)) deficiency of the enzyme methylmalonyl-CoA mutase (MUT). The severe metabolic instability and increased mortality experienced by many affected individuals,...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2015.092

    authors: Harrington EA,Sloan JL,Manoli I,Chandler RJ,Schneider M,McGuire PJ,Calcedo R,Wilson JM,Venditti CP

    更新日期:2016-05-01 00:00:00

  • Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon.

    abstract::Direct arterial gene transfer has been previously achieved using double-balloon catheters and perforated balloons, in most cases facilitated by the use of cationic liposomes or viral vectors. These gene delivery systems, however, have been compromised by issues relating to efficacy and/or safety, and furthermore requi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1993.4.6-749

    authors: Riessen R,Rahimizadeh H,Blessing E,Takeshita S,Barry JJ,Isner JM

    更新日期:1993-12-01 00:00:00

  • Enhanced gene expression conferred by stepwise modification of a nonprimate lentiviral vector.

    abstract::The practical application of gene transfer as a treatment for genetic diseases such as cystic fibrosis or hemophilia has been hindered, in part, by low efficiencies of vector delivery and transgene expression. We demonstrated that a feline immunodeficiency virus (FIV)-based lentiviral vector pseudotyped with the envel...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.127

    authors: Sinn PL,Goreham-Voss JD,Arias AC,Hickey MA,Maury W,Chikkanna-Gowda CP,McCray PB Jr

    更新日期:2007-12-01 00:00:00

  • The Future Looks Brighter After 25 Years of Retinal Gene Therapy.

    abstract::The first report of in vivo gene delivery to the retina dates back to 1987 when a retroviral vector was injected intraocularly in newborn mice. Later came the observation that retinal cells could be successfully transduced using adenoviral and then adeno-associated and lentiviral vectors. By 2000, it had become clear ...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2017.164

    authors: Auricchio A,Smith AJ,Ali RR

    更新日期:2017-11-01 00:00:00